The FDA granted 510(k) clearance for HyHub and HyHub Duo devices on July 21, 2025. Kristina Allikmets is senior vice president for Takeda.
1 report, 1 independent
Updated Jul 21
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The FDA granted 510(k) clearance for HyHub and HyHub Duo devices on July 21, 2025. Kristina Allikmets is senior vice president for Takeda.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Takeda Pharmaceutical Company
Japanese pharmaceutical company
Nothing else this week.
Related events
- Philips received FDA 510(k) clearance for a sensor.
- FDA granted 510k clearance for the ZEISS CLINIC 360 software solution.
- An unnamed company secured regulatory approval in July 2025, leading to a $2.5 million milestone reported today.
- FDA and Pfizer are seeking regulatory approval for their products.
- Modular is seeking FDA clearance for its Pivot product.
Coverage
Newest first; wire copies grouped- Business WireTakeda Receives FDA 510(k) Clearance for HyHubTM and HyHubTM Duo Devices to Simplify HYQVIA® Administration HyHub and HyHub Duo Reduce the Number of Steps Required to Prepare HYQVIA1 First Devices Cu